Close

Axonics® Reports Third Quarter 2020 Results Nov 4, 2020 04:00PM
Pre-Open Stock Movers 07/02: (NIO) (CAR) (TSLA) Higher; (DSS) (CULP) (ZOM) Lower (more...) Jul 2, 2020 09:24AM
Axonics Modulation Tech (AXNX) Announces Health Canada Approves Full-Body MRI Labeling for the Axonics® Sacral Neuromodulation System Dec 2, 2019 06:17AM
Health Canada Approves Full-Body MRI Labeling for the Axonics® Sacral Neuromodulation System Dec 2, 2019 06:00AM
Axonics Modulation Technologies Inc. (AXNX) Reports FDA Approval for Use of Full-Body MRI for Pivotal Study Patients Jun 18, 2019 06:11AM


Jun 18, 2019 06:00AM Axonics® Announces U.S. Food & Drug Administration Approves Use of Full-Body MRI for Pivotal Study Patients
Feb 22, 2019 11:31AM Axonics (AXNX) Says it was Granted Expanded CE Mark Label
Feb 22, 2019 11:30AM Axonics® Granted Expanded CE Mark Label; First and Only Sacral Neuromodulation System Approved for Use with Full-Body MRI Scans
Feb 12, 2019 06:12AM Axonics Modulation Technologies Inc. (AXNX) Reports FDA Submission of Test Data for Conditional Full Body MRI Labeling Approval for r-SNM System1
Feb 12, 2019 06:00AM Axonics® Submits Full Body MRI Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System